Basic fibroblast growth factor enters trials for peripheral vascular disease.
Fricker
J
J
D000367:Age Factors; D017322:Clinical Trials, Phase II as Topic; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy / Q000628:therapy; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors
D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2